Research and Development Expenditure. Licensee agrees to spend an amount not less than the amount set forth on Schedule 3 for the periods indicated on such Schedule in performing research and development with respect to the Technology.
Research and Development Expenditure. 161 The domestic law research and development provisions are excluded from the operation of this new Article 23A. It follows that Australia will be able to continue to apply its domestic law rules concerning access to concessions in respect of research and development expenditure. Currently, these concessions are only available to companies that are incorporated in Australia. [New Article 23A, subparagraph 5
Research and Development Expenditure. The insurance provided by this Section shall extend to include the following:
a) in the event of research and development by the insured in consequence of an incident being:
i) totally interrupted or totally given over to the re-working of projects affected by the incident the underwriter shall pay for each working week during the indemnity period one-fiftieth of the expenditure on such research and development incurred by the insured during the financial year immediately preceding the date of the incident; or
ii) partially interrupted or partially given over to the re-working of projects affected by the incident the underwriter shall pay for each working week during the indemnity period an equitable proportion of one-fiftieth of the expenditure on such research and development incurred by the insured during the financial year immediately preceding the date of the incident based upon the time rendered ineffective by reason of the incident;
b) the additional expenditure reasonably and necessarily incurred solely in consequence of the incident in order to minimise such interruption but the amount payable under this clause shall not exceed the amount that would have been payable for loss in respect of research expenditure if no such additional expenditure had been incurred;
c) any reduction in the amount of grants endowments and other financial contributions made to the insured pursuant to written agreements in effect at the inception of this policy (or later as per sub-paragraph (ii) below) to further research and development operations in consequence of such incident provided that the insured;
i) reports the value of such agreements to the underwriter prior to the inception of this policy; and
ii) reports the value of any agreements executed after inception of this policy within 90 days of their execution; and
iii) reports any amendment to such agreements within 90 days of the execution of such amendments; and
iv) continues the research and development operation Less any sum saved during the indemnity period in respect of such expenditure as may cease or be reduced in consequence of the incident. The liability of the underwriter shall not exceed GBP5000 for any one occurrence.
Research and Development Expenditure. The First And Annual Premium In Respect of Research And Development Expenditure Is Provisional And Is Based Upon The Estimated Research And Development Expenditure. Not Later Than Six Months After The Expiry of Each Period of Insurance The Insured Shall Provide The Company With A Declaration, Confirmed By The
Research and Development Expenditure. Licensee agrees to fund, directly ------------------------------------ or indirectly with or through strategic alliances, joint ventures and other entities, including without limitation application of matching funds or grants provided by governmental or quasi-governmental agencies or entities, research and development work; directed to the demonstration and further development of the Inventions in the following amounts in the following periods:
(a) not less than $250,000.00 not later than June 30, 1995; and
(b) not less than $750,000.00 (including the amounts referred to in Section 3.4(a)) not later than June 30, 1996; and
(c) not less than $1,500,000.00 (including the amounts referred to in Sections 3.4(a) and 3.4(b)) not later than June 30, 1997; and
(d) not less than $2,500,000.00 (including the amounts referred to in Sections 3.4(a), 3.4(b) and 3.4(c)) not later than June 30, 1998. Licensee agrees to give consideration to the performance of each aspect of the work described above at ANL, taking into account the resources and capacities of ANL relevant to the work. Any such work will be performed by ANL pursuant to agreements to be negotiated in good faith between ANL and Licensee.
Research and Development Expenditure. Licensee agrees to fund, directly ------------------------------------ or indirectly with or through strategic alliances, joint ventures and other entities, including without limitation application of matching funds or grants provided by governmental or quasi-governmental agencies or entities, research and development work; directed to the demonstration and further development of the Inventions in the following amounts in the following periods:
(a) not less than * not later than June 30, 1995; and
(b) not less than * (including the amounts referred to in Section 3.4(a)) not later than June 30, 1996; and
(c) not less than * (including the amounts referred to in Sections 3.4(a) and 3.4(b)) not later than June 30, 1997; and
(d) not less than * (including the amounts referred to in Sections 3.4(a), 3.4(b) and 3.4(c)) not later than June 30, 1998. Licensee agrees to give consideration to the performance of each aspect of the work described above at ANL, taking into account the resources and capacities of ANL relevant to the work. Any such work will be performed by ANL pursuant to agreements to be negotiated in good faith between ANL and Licensee.
Research and Development Expenditure. Loss will be calculated as follows:
Research and Development Expenditure. (a) All research expenditure is to be written off to the profit and loss account in the year in which it is incurred;
(b) All development expenditure is to be written-off to the profit and loss account in the year in which it is incurred unless the Purchaser is satisfied as to the technical, commercial and financial viability of the individual project, in which case the expenditure should be capitalised within fixed assets and amortised over the period which the company is expected to benefit.
Research and Development Expenditure. Expenditure on research and development is written off against earnings as incurred, except that when a project reaches the stage where such expenditure is expected to be recouped through development or sale, all subsequent expenditures are capitalised. Unamortised costs are reviewed at each balance date to determine the amount (if any) that is no longer recoverable and any amount so identified is written off.
